Holding RIPK1 on the Ubiquitin Leash in TNFR1 Signaling

被引:151
|
作者
Peltzer, Nieves [1 ]
Darding, Maurice [1 ]
Walczak, Henning [1 ]
机构
[1] UCL, UCL Canc Inst, Ctr Cell Death Canc & Inflammat CCCI, Mortimer St, London WC1E 6BT, England
基金
英国惠康基金;
关键词
NF-KAPPA-B; CAUSES EMBRYONIC LETHALITY; SEVERE LIVER DEGENERATION; APOPTOSIS PROTEIN CIAP2; CHAIN ASSEMBLY COMPLEX; SHARPIN-DEFICIENT MICE; CELL-DEATH; LINEAR UBIQUITIN; IN-VIVO; C-FLIP;
D O I
10.1016/j.tcb.2016.01.006
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The kinase RIPK1 is an essential signaling node in various innate immune signaling pathways being most extensively studied in the TNFR1 signaling pathway. TNF signaling can result in different biological outcomes including gene activation and cell death induction in the form of apoptosis or necroptosis. RIPK1 is believed to be crucial for regulating the balance between these opposing outcomes. It is therefore not surprising that RIPK1 is highly regulated, most notably by phosphorylation, ubiquitination, and their respective reversals. In this review, we discuss the biological functions of RIPK1 within the context of TNFR1 signaling. Finally, we discuss recent advances in the knowledge on three ubiquitin E3 ligases that exert regulatory functions on RIPK1 signaling: cIAP1, cIAP2, and LUBAC.
引用
收藏
页码:445 / 461
页数:17
相关论文
共 50 条
  • [31] TRAF6 regulates the abundance of RIPK1 and inhibits the RIPK1/RIPK3/MLKL necroptosis signaling pathway and affects the progression of colorectal cancer
    Lin, Penghang
    Lin, Chunlin
    He, Ruofan
    Chen, Hui
    Teng, Zuhong
    Yao, Hengxin
    Liu, Songyi
    Hoffman, Robert M. M.
    Ye, Jianxin
    Zhu, Guangwei
    CELL DEATH & DISEASE, 2023, 14 (01)
  • [32] TRAF6 regulates the abundance of RIPK1 and inhibits the RIPK1/RIPK3/MLKL necroptosis signaling pathway and affects the progression of colorectal cancer
    Penghang Lin
    Chunlin Lin
    Ruofan He
    Hui Chen
    Zuhong Teng
    Hengxin Yao
    Songyi Liu
    Robert M. Hoffman
    Jianxin Ye
    Guangwei Zhu
    Cell Death & Disease, 14
  • [33] Apoptotic signaling by TNFR1 is inhibited by the α2-6 sialylation, but not α2-3 sialylation, of the TNFR1 N-glycans
    Hwang, Jihye
    Rao, Tejeshwar C.
    Tao, Jiahui
    Sha, Bingdong
    Narimatsu, Yoshiki
    Clausen, Henrik
    Mattheyses, Alexa L.
    Bellis, Susan L.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2025, 301 (01)
  • [34] RIPK1 and RIPK3 in antibacterial defence
    Yeap, Hui Wen
    Chen, Kaiwen W.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2022, 50 (06) : 1583 - 1594
  • [35] Inhibition of RIPK1 kinase does not affect diabetes development: β -Cells survive RIPK1 activation
    Takiishi, Tatiana
    Xiao, Peng
    Franchimont, Marie
    Gilglioni, Eduardo H.
    Arroba, Erick N.
    Gurzov, Esteban N.
    Bertrand, Mathieu J. M.
    Cardozo, Alessandra K.
    MOLECULAR METABOLISM, 2023, 69
  • [36] TNFR1 membrane reorganization promotes distinct modes of TNFα signaling
    Morton, Penny E.
    Perrin, Camille
    Levitt, James
    Matthews, Daniel R.
    Marsh, Richard J.
    Pike, Rosemary
    McMillan, David
    Maloney, Alison
    Poland, Simon
    Ameer-Beg, Simon
    Parsons, Maddy
    SCIENCE SIGNALING, 2019, 12 (592)
  • [37] Hematopoietic TNFR1 signaling mediates protection in a mouse model of arthritis
    Scheinman, Robert I.
    Raman, Thiagarajan
    Williams-Skipp, Cheryll
    Derry, Molly
    Helfer, Christine
    JOURNAL OF IMMUNOLOGY, 2009, 182
  • [38] More to Life than NF-κB in TNFR1 Signaling
    Ting, Adrian T.
    Bertrand, Mathieu J. M.
    TRENDS IN IMMUNOLOGY, 2016, 37 (08) : 535 - 545
  • [39] RIPK1 protects epithelial cells
    Kim Baumann
    Nature Reviews Molecular Cell Biology, 2014, 15 : 629 - 629
  • [40] Advances in RIPK1 kinase inhibitors
    Chen, Lu
    Zhang, Xiaoqin
    Ou, Yaqing
    Liu, Maoyu
    Yu, Dongke
    Song, Zhiheng
    Niu, Lihong
    Zhang, Lijuan
    Shi, Jianyou
    FRONTIERS IN PHARMACOLOGY, 2022, 13